GovChime
Notice ID: 1a90358cb2da4bc8a6f6e49410962b7bSolicitation

Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders

Archived on March 29, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
5:00 PM UTC−04:00
Posted
March 1, 2022
Notice type
Solicitation
NAICS
541714: Research and Development in Biotechnology (except Nanobiotechnology)
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N95022R00013
Notice ID
1a90358cb2da4bc8a6f6e49410962b7b

Description

Amendment 2: Q&A part 2 and revised Section M posted Amendment 1: Q&A part 1 posted and proposal due date extended The National Institute of Neurological Disorders and Stroke (NINDS) has a need for current Good Manufacturing Practices (cGMP) manufacturing and Good Laboratory Practice (GLP) nonclinical (preclinical) support services to support translational development of therapeutic biotechnology products (Biologics) for NIH drug discovery and development programs. To that end, several NIH programs are being launched or expanded to provide support for investigators developing medical interventions for neurological disorders, including the NIH Blueprint Neurotherapeutics (BPN) network, the NINDS Ultra-Rare Gene Therapy (URGenT) program, and the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP). Contractors must provide support for both Biologics cGMP manufacturing and GLP nonclinical services, including execution of the studies and completion of study reports and documentation that will enable regulatory filing and evaluation of biological therapeutics in clinical trials for NIH drug development programs. These services may be provided through a combination of internally executed studies and subcontracted work. All work in support of NIH biologics programs will be awarded through issuance of task orders against indefinite delivery, indefinite quantity (IDIQ) contracts. Please see the RFP and attachments for more information and review all instructions carefully. All proposals must be submitted through NIH's electronic Contract Proposal Submission (eCPS) and contain all required information/documentation. Additonally, all offerors must have an active SAM registration at the time of proposal submission to be considered for award.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95022R00013
  1. Pre-Solicitation
  2. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. 9×
    Pre-SolicitationDec 2, 2021

    Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders

    Notice 46501c81fe8b45ff87481bb2028fd1a2 on SAM.gov

  2. 5×
    SolicitationCurrentJan 25, 2022

    Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders

    Notice 1a90358cb2da4bc8a6f6e49410962b7b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95022R00013

Archive Date

Mar 29, 2022

Office Address

Bethesda, MD, 20892